一种低强度营养干预,针对妊娠糖尿病中的甘油三:一个可行性RCT
Kai Liu1,2,3, Georgia S Clarke1,2,3, Jessica A Grieger1,2,3
1Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
The Journal of clinical endocrinology and metabolism
|May 16, 2025
概括
针对妊娠糖尿病 (GDM) 的低强度饮食干预是可行的和可以接受的. 这种专注于全食物的方法在孕产妇的饮食和出生体重方面显示出有前途的结果,因此需要在更大的试验中进行进一步的研究.
科学领域:
- 产科和妇科 产科和妇科
- 营养科学 营养科学
- 内分泌学 在内分泌学.
背景情况:
- 孕期糖尿病 (GDM) 的管理通常涉及标准护理.
- 在GDM怀孕期间升的甘油三酸是令人担忧的.
- 饮食干预可以帮助管理GDM并发症.
研究的目的:
- 评估GDM妇女低强度饮食干预的可行性.
- 为了将这种干预与标准GDM管理进行比较.
- 评估其对母亲饮食和婴儿出生体重的影响.
主要方法:
- 随机对照试验,38名女性患有GDM.
- 干预组接受了标准的护理,以及关于减少超加工食品和增加全食食品的咨询.
- 主要结局是研究可行性;次要结局包括饮食摄入量,甘油三,葡萄糖和出生体重.
主要成果:
- 招聘率很低 (每周1次),但保留率很高 (89.5%).
- 干预组的女性减少了超加工食品的摄入量,增加了坚果的消费量.
- 血甘油三度没有显著差异;然而,标准护理组的平均出生体重较高.
结论:
- 在GDM中减弱甘油三的饮食干预是可行的和可以接受的.
- 积极的孕产妇饮食改善和理想的出生体重结果表明潜在的好处.
- 需要在更大的随机对照试验中进行进一步的调查.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...


